Record Information |
---|
Version | 2.0 |
---|
Created at | 2024-03-06 08:17:06 UTC |
---|
Updated at | 2024-09-03 04:19:43 UTC |
---|
NP-MRD ID | NP0332594 |
---|
Natural Product DOI | https://doi.org/10.57994/1854 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Compound 12b |
---|
Description | Compound 12b was first documented in 2022 (PMID: 36000168). Based on a literature review a significant number of articles have been published on Compound 12b (PMID: 39022355) (PMID: 38731613) (PMID: 38660526) (PMID: 38430971) (PMID: 38428537) (PMID: 38311010). |
---|
Structure | CCCCCCCCCCCCCC=CCCC=CCCCCCCCCCCCCCCCCCCCCCCCCCC=CCCC=CCC InChI=1S/C52H98/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-39-41-43-45-47-49-51-52-50-48-46-44-42-40-38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h5,7,13,15,28,30,36,38H,3-4,6,8-12,14,16-27,29,31-35,37,39-52H2,1-2H3 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C33H38O10 |
---|
Average Mass | 594.6570 Da |
---|
Monoisotopic Mass | 594.24650 Da |
---|
IUPAC Name | dopentaconta-3,7,34,38-tetraene |
---|
Traditional Name | dopentaconta-3,7,34,38-tetraene |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H][C@@]1(CO[C@@H](C2=CC(OC)=C(OC)C=C2)[C@]1([H])COC(C)=O)[C@H](OC(=O)[C@@H](OC)C1=CC=CC=C1)C1=CC=C(OC)C(OC)=C1 |
---|
InChI Identifier | InChI=1S/C33H38O10/c1-20(34)41-18-24-25(19-42-30(24)22-12-14-26(36-2)28(16-22)38-4)31(23-13-15-27(37-3)29(17-23)39-5)43-33(35)32(40-6)21-10-8-7-9-11-21/h7-17,24-25,30-32H,18-19H2,1-6H3/t24-,25+,30+,31-,32+/m1/s1 |
---|
InChI Key | GAAGPAPKKCIDKB-KGOWHPHGSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
COSY NMR | [1H, 1H] NMR Spectrum (2D, 500 MHz, CDCl3, experimental) | Not Available | Keio University | Haruhisa Kikuchi | 2024-03-06 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, CDCl3, experimental) | Not Available | Keio University | Haruhisa Kikuchi | 2024-03-06 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Not Available |
---|
Chemical Taxonomy |
---|
Classification | Not classified |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Kumar K, Sihag B, Patil MT, Singh R, Sakala IG, Honda-Okubo Y, Singh KN, Petrovsky N, Salunke DB: Design and Synthesis of Polyphenolic Imidazo[4,5-c]quinoline Derivatives to Modulate Toll Like Receptor-7 Agonistic Activity and Adjuvanticity. ACS Pharmacol Transl Sci. 2024 Jun 12;7(7):2063-2079. doi: 10.1021/acsptsci.4c00163. eCollection 2024 Jul 12. [PubMed:39022355 ]
- Zhu XD, Corona A, Maloccu S, Tramontano E, Wang S, Pannecouque C, De Clercq E, Meng G, Chen FE: Structure-Based Design of Novel Thiazolone[3,2-a]pyrimidine Derivatives as Potent RNase H Inhibitors for HIV Therapy. Molecules. 2024 May 3;29(9):2120. doi: 10.3390/molecules29092120. [PubMed:38731613 ]
- El Sayed D, El Rayes SM, Soliman HA, AlBalaa IE, Alturki MS, Al Khzem AH, Alsharif MA, Nafie MS: Synthesis of novel phthalazine-based derivatives with potent cytotoxicity against HCT-116 cells through apoptosis and VEGFR2 inhibition. RSC Adv. 2024 Apr 24;14(19):13027-13043. doi: 10.1039/d4ra02103g. eCollection 2024 Apr 22. [PubMed:38660526 ]
- Fang S, Huang X, Cai F, Qiu G, Lin F, Cai X: Design, synthesis and molecular docking of novel D-ring substituted steroidal 4,5-dihydropyrazole thiazole derivatives that act as iNOS/COX-2 inhibitors with potent anti-inflammatory activity against LPS-induced RAW264.7 macrophage cells. J Steroid Biochem Mol Biol. 2024 Jun;240:106478. doi: 10.1016/j.jsbmb.2024.106478. Epub 2024 Feb 29. [PubMed:38430971 ]
- Li Y, Hwang N, Snedeker A, Lemon SM, Noe D, Sun L, Clement JA, Zhou T, Tang L, Block T, Du Y: "PROTAC" modified dihydroquinolizinones (DHQs) that cause degradation of PAPD-5 and inhibition of hepatitis A virus and hepatitis B virus, in vitro. Bioorg Med Chem Lett. 2024 Apr 1;102:129680. doi: 10.1016/j.bmcl.2024.129680. Epub 2024 Feb 29. [PubMed:38428537 ]
- Helsen C, Karypidou K, Thomas J, De Leger W, Nguyen T, Joniau S, Voet A, Dehaen W, Claessens F: Discovery of a novel androgen receptor antagonist, MEL-6, with stereoselective activity and optimization of its metabolic stability. J Steroid Biochem Mol Biol. 2024 May;239:106476. doi: 10.1016/j.jsbmb.2024.106476. Epub 2024 Feb 3. [PubMed:38311010 ]
- Abdelhamed AM, Hassan RA, Kadry HH, Helwa AA: Novel pyrazolo[3,4-d]pyrimidine derivatives: design, synthesis, anticancer evaluation, VEGFR-2 inhibition, and antiangiogenic activity. RSC Med Chem. 2023 Nov 7;14(12):2640-2657. doi: 10.1039/d3md00476g. eCollection 2023 Dec 13. [PubMed:38107182 ]
- Krishnamoorthy R, Anaikutti P: Iodine catalyzed synthesis of imidazo[1,2-a]pyrazine and imidazo[1,2-a]pyridine derivatives and their anticancer activity. RSC Adv. 2023 Dec 13;13(51):36439-36454. doi: 10.1039/d3ra07842f. eCollection 2023 Dec 8. [PubMed:38093732 ]
- Salem ME, Abdullah AH, Ibrahim NS, Zaki MEA, Elwahy AHM, Abdelhamid IA: Novel Scaffolds Based on Bis-thiazole Connected to Quinoxaline or Thienothiophene through 2-Phenoxy-N-arylacetamide Groups as New Hybrid Molecules: Synthesis, Antibacterial Activity, and Molecular Docking Investigations. ACS Omega. 2023 Nov 10;8(46):44312-44327. doi: 10.1021/acsomega.3c07125. eCollection 2023 Nov 21. [PubMed:38027350 ]
- Li Y, Liu S, Xu X, Xu J, Yang L, Hu L: Integrated molecular modeling and dynamics approaches revealed the mechanism of selective inhibition of HDAC6/8. J Biomol Struct Dyn. 2023 Oct 23:1-14. doi: 10.1080/07391102.2023.2272751. [PubMed:37870047 ]
- Luo B, Zhao Y, Zhang J, Li W, Liu M, Yang M, Wei L, Liu Y, Wen B, Qu L: Design, Synthesis, and Antifungal Activities of Novel Pyrazole-4-carboxamide Derivatives Containing an Ether Group as Potential Succinate Dehydrogenase Inhibitors. J Agric Food Chem. 2023 Jun 21;71(24):9255-9265. doi: 10.1021/acs.jafc.3c00116. Epub 2023 Jun 7. [PubMed:37283465 ]
- Dai R, Wei X, Li T, Lee J, Gao J, Chen Y, Su G, Zhao Y: Synthesis and Antitumor Activity of Panaxadiol Pyrazole and Isooxazole Derivatives. Chem Biodivers. 2023 Aug;20(8):e202300507. doi: 10.1002/cbdv.202300507. Epub 2023 Jul 7. [PubMed:37279052 ]
- Lang JJ, Lv Y, Kobe B, Chen H, Tan Y, Chen L, Wang X, Mi P, Zheng X, Lin YW: Discovery of C-5 Pyrazole-Substituted Pyrrolopyridine Derivatives as Potent and Selective Inhibitors for Janus Kinase 1. J Med Chem. 2023 May 25;66(10):6725-6742. doi: 10.1021/acs.jmedchem.3c00050. Epub 2023 May 10. [PubMed:37163463 ]
- Ren Y, Wang Y, Liu J, Liu T, Yuan L, Wu C, Yang Z, Chen J: X-ray Crystal Structure-Guided Discovery of Novel Indole Analogues as Colchicine-Binding Site Tubulin Inhibitors with Immune-Potentiating and Antitumor Effects against Melanoma. J Med Chem. 2023 May 25;66(10):6697-6714. doi: 10.1021/acs.jmedchem.3c00011. Epub 2023 May 5. [PubMed:37145846 ]
- Guo R, Cui M, Li X, Wu M, Xu F, Zhang Y, Wang C, Feng P, Wang J, Huo S, Luo Z, Xing R, Gu J, Shi X, Liu Y, Wang L: Design, synthesis and biological evaluation of pyrrolopyrimidine derivatives as novel and selective positive modulator of the small conductance Ca(2+)-activated K(+) channels. Eur J Med Chem. 2023 Jun 5;254:115353. doi: 10.1016/j.ejmech.2023.115353. Epub 2023 Apr 8. [PubMed:37068385 ]
- Sun X, Yu X, Zhao Y, Xing L, Na L, Chen Z, Xiao Z, Dai H, Yu J, Long S, Wang Q, Shi X, Guan Z, Lei M, Yang Z: Cyclic diguanylate analogues: Facile synthesis, STING binding mode and anti-tumor immunity delivered by cytidinyl/cationic lipid. Eur J Med Chem. 2023 Feb 5;247:115053. doi: 10.1016/j.ejmech.2022.115053. Epub 2022 Dec 26. [PubMed:36587419 ]
- Gaber AA, Sobhy M, Turky A, Abdulwahab HG, Al-Karmalawy AA, Elhendawy MA, Radwan MM, Elkaeed EB, Ibrahim IM, Elzahabi HSA, Eissa IH: Discovery of new 1H-pyrazolo[3,4-d]pyrimidine derivatives as anticancer agents targeting EGFR(WT) and EGFR(T790M). J Enzyme Inhib Med Chem. 2022 Dec;37(1):2283-2303. doi: 10.1080/14756366.2022.2112575. [PubMed:36000168 ]
- Wang Y, Qian S, Zhao F, Wang Y, Li J: Terazosin Analogs Targeting Pgk1 as Neuroprotective Agents: Design, Synthesis, and Evaluation. Front Chem. 2022 Jul 26;10:906974. doi: 10.3389/fchem.2022.906974. eCollection 2022. [PubMed:35958233 ]
- Li D, Zhang L: Structure Prediction and Potential Inhibitors Docking of Enterovirus 2C Proteins. Front Microbiol. 2022 Apr 29;13:856574. doi: 10.3389/fmicb.2022.856574. eCollection 2022. [PubMed:35572704 ]
- Mahnashi MH, El-Senduny FF, Alshahrani MA, Abou-Salim MA: Design, Synthesis, and Biological Evaluation of a Novel VEGFR-2 Inhibitor Based on a 1,2,5-Oxadiazole-2-Oxide Scaffold with MAPK Signaling Pathway Inhibition. Pharmaceuticals (Basel). 2022 Feb 18;15(2):246. doi: 10.3390/ph15020246. [PubMed:35215358 ]
|
---|